Celularity (CELUW) Other Accumulated Expenses (2021 - 2025)
Celularity (CELUW) reported Other Accumulated Expenses of $300000.0 for Q4 2025, down 90.15% quarter-over-quarter from $3.0 million in Q3 2021.
Celularity (CELUW) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
Celularity (CELUW) has 2 years of Other Accumulated Expenses data on file, last reported at $300000.0 in Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $300000.0 (changed N/A YoY), and the FY2025 annual result was $300000.0, changed N/A from the prior year.
- Other Accumulated Expenses retreated to $300000.0 in Q4 2025 per CELUW's latest filing, from $3.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $3.0 million in Q3 2021 and troughed at $300000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2021 | 3.05 Mn |